Almac
New Products Posted to GenomeWeb: Guardant Health, Karius, Tempus, Almac Diagnostics, Zeiss, More
New products and services recently posted on GenomeWeb.
NCCN Calls ctDNA Emerging Colon Cancer Prognostic Marker, Does Not Back Use Outside Clinical Trials
The panel noted limited data on whether recurrence risk scores from ctDNA testing or multigene assays predict chemotherapy benefit among colon cancer patients.
The new tests, once developed, will be used for selecting patients who might best benefit from therapies for kidney disease, nonalcoholic steatohepatitis, and respiratory disease.
Almac NGS-Based CDx Gets CE Mark
Almac said that the assay will be used in a clinical study of repotrectinib (TPX-0005), an investigational, next-generation tyrosine kinase inhibitor.
The test relies on a signature that Almac developed for stratifying breast cancer patients, but which, as the researchers showed, can be used in other cancers as well.
Apr 25, 2017
Nov 12, 2015
Illumina, Almac to Collaborate on NGS CDx Assays
Jun 22, 2015
Almac, OncoMed to Develop CDx for R-Spondin 3
Aug 22, 2012
Apr 3, 2012
Feb 3, 2012